“More funds are necessary for research on amyotrophic lateral sclerosis (ALS). More resources to aid more serious and controlled research for cures that slow the degenerating effects of the disease, for example using stem cells”, said Claudio Sabelli, an ALS patient and member of the Board of the ‘Viva la Vita’ society, writing with a visually controlled computer that communicates for him, commenting about announcements on research to fight ALS.
Sabelli said, “As a patient, I have an opinion that is not supported by facts for the simple reason that there are no new developments. I
The Health Minister recently held a press conference to launch a program to strengthen the public biobank network, considering that currently on 20% of donations are completed successfully. An informative pamphlet was also distributed about “The appropriate use of umbilical cord stem cells“.
The StemWay Biotech company, through its Vice-President Dr. Paolo Rubini, in complete agreement with other biobanks in Italy, with great surprise and dismay, stressed that unfortunately, the measure seems to be more against the autologous conservation of stem cells rather than in favor of donation. As for the scientific statements contained in the informative pamphlet